Who this is for
Oncology, infusion, specialty pharmacy, home infusion, anesthesia, ASC, and care-operation teams that already check public shortage records manually.
Guide
How to monitor FDA drug shortages.
To monitor FDA drug shortages, start with the official FDA shortage pages, use openFDA when you need machine-readable records, define organization-level watch terms, and keep a dated source trail for internal review. FormularySignal automates that loop by checking public FDA/openFDA records against your watchlist and sending source-linked Signal Cards.
Last updated April 28, 2026.
What FormularySignal does
It checks public FDA/openFDA shortage records on schedule, compares records with your watch terms, and sends timestamped Signal Cards with source links and exports.
What it does not do
It does not provide clinical, procurement, purchasing, sourcing, substitution, compounding, dispensing, inventory, local-availability, legal, or emergency advice.
Practical monitoring checklist
- Choose public sources to review: FDA shortage pages and openFDA shortage records are the core FormularySignal sources.
- Define organization-level watch terms: drug names, manufacturers, NDCs, categories, or shortage terms. Do not use PHI.
- Record timestamps and source URLs so internal review can verify the public record later.
- Use sample artifacts before buying: Signal Card, weekly digest, public signals, and data sources.
- Keep action decisions inside your existing professional review workflow.
Official public records can change, and national shortage status may differ from local availability. FormularySignal is independent and is not affiliated with or endorsed by FDA.